These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1819726)
21. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Stewart AG; Dusting GJ Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058 [TBL] [Abstract][Full Text] [Related]
22. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin. Dixon EJ; Wilsoncroft P; Robertson DN; Page CP Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238 [TBL] [Abstract][Full Text] [Related]
23. Enterolobin induces rat paw oedema independently of PAF-acether. Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984 [TBL] [Abstract][Full Text] [Related]
24. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996 [TBL] [Abstract][Full Text] [Related]
25. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro. Lohde C; Bahr T; Labes D; Grupe R Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025 [TBL] [Abstract][Full Text] [Related]
26. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine]. Kulikov VI; Muzia GI Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455 [TBL] [Abstract][Full Text] [Related]
27. Ro 19-3704 directly inhibits immunoglobulin E-dependent mediator release by a mechanism independent of its platelet-activating factor antagonist properties. Gilfillan AM; Wiggan GA; Hope WC; Patel BJ; Welton AF Eur J Pharmacol; 1990 Feb; 176(3):255-62. PubMed ID: 1691711 [TBL] [Abstract][Full Text] [Related]
28. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat. McCormack DG; Barnes PJ; Evans TW Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602 [TBL] [Abstract][Full Text] [Related]
29. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. De Kimpe SJ; Thiemermann C; Vane JR Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795 [TBL] [Abstract][Full Text] [Related]
30. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists. Koltai M; Hosford D; Braquet P J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981 [No Abstract] [Full Text] [Related]
32. Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists. Mathison R; Davison JS; Befus AD Br J Pharmacol; 1992 Jun; 106(2):263-6. PubMed ID: 1393261 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Hu W; Kinnaird AA; Man RY Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337 [TBL] [Abstract][Full Text] [Related]
34. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. Braquet P; Hosford D J Ethnopharmacol; 1991 Apr; 32(1-3):135-9. PubMed ID: 1881152 [TBL] [Abstract][Full Text] [Related]
35. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart. Viossat I; Chapelat M; Chabrier PE; Braquet P Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972 [TBL] [Abstract][Full Text] [Related]
36. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists. Vásquez-Bravo YL; Russo M; Jancar S J Lipid Mediat; 1993 Nov; 8(3):135-44. PubMed ID: 8268459 [TBL] [Abstract][Full Text] [Related]
37. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975 [TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. Faden AI; Tzendzalian PA Am J Physiol; 1992 Oct; 263(4 Pt 2):R909-14. PubMed ID: 1415805 [TBL] [Abstract][Full Text] [Related]
39. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists. Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436 [No Abstract] [Full Text] [Related]
40. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]